0001140361-13-047323.txt : 20131223 0001140361-13-047323.hdr.sgml : 20131223 20131223140229 ACCESSION NUMBER: 0001140361-13-047323 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131223 DATE AS OF CHANGE: 20131223 EFFECTIVENESS DATE: 20131223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STEM CELL THERAPEUTICS CORP CENTRAL INDEX KEY: 0001392333 IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-208615 FILM NUMBER: 131294190 BUSINESS ADDRESS: STREET 1: 96 SKYWAY AVENUE CITY: TORONTO STATE: A6 ZIP: M9W 4Y9 BUSINESS PHONE: (416) 457-4670 MAIL ADDRESS: STREET 1: 96 SKYWAY AVENUE CITY: TORONTO STATE: A6 ZIP: M9W 4Y9 D 1 primary_doc.xml X0707 D LIVE 0001392333 STEM CELL THERAPEUTICS CORP 96 Skyway Avenue Toronto A6 ONTARIO, CANADA M9W 4Y9 416-457-4670 ONTARIO, CANADA None None Corporation true Niclas Stiernholm 96 Skyway Avenue Toronto A6 ONTARIO, CANADA M9W 4Y9 Executive Officer Director Robert Uger 96 Skyway Avenue Toronto A6 ONTARIO, CANADA M9W 4Y9 Executive Officer Penka Petrova 96 Skyway Avenue Toronto A6 ONTARIO, CANADA M9W 4Y9 Executive Officer James Todd Parsons 96 Skyway Avenue Toronto A6 ONTARIO, CANADA M9W 4Y9 Executive Officer David Geoffrey Peter Allan 96 Skyway Avenue Toronto A6 ONTARIO, CANADA M9W 4Y9 Director James Michael DeMesa 96 Skyway Avenue Toronto A6 ONTARIO, CANADA M9W 4Y9 Director Henry G. Friesen 96 Skyway Avenue Toronto A6 ONTARIO, CANADA M9W 4Y9 Director Michael Moore 96 Skyway Avenue Toronto A6 ONTARIO, CANADA M9W 4Y9 Director Ronald Dean Peterson 96 Skyway Avenue Toronto A6 ONTARIO, CANADA M9W 4Y9 Director Calvin Ralph Stiller 96 Skyway Avenue Toronto A6 ONTARIO, CANADA M9W 4Y9 Director Biotechnology Decline to Disclose 06b false 2013-12-13 false true true true true Offered Units = Units & Preferred Units; Units = 1 common share & 3/4 common share warrant; Preferred Units = 1 series I convertible preferred share & 3/4 common share warrant. false 0 ROTH Capital Partners, LLC 15407 None None 730 Fifth Ave., 25th Floor New York NY NEW YORK 10019 CA CALIFORNIA CT CONNECTICUT MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK false Bloom Burton & Co. Inc. None None None 65 Front Street East, Suite 300 Toronto A6 ONTARIO, CANADA M5E 1B5 false 60697057 30298825 30398232 Aggregate offering includes amout that may be received by Issuer upon exercise of warrants. Each whole warrant may be exercised for one common share at an exercise price of CDN$0.28 per share for a period of 5 years after Closing. false 22 1817929 0 In addition to cash commission, agents may also receive up to 5,014,839 options. Each option may be exercised for one common share at a price of CDN$0.21 per share for a period of 24 months from Closing. 0 false STEM CELL THERAPEUTICS CORP /s/ James T. Parsons James T. Parsons Chief Financial Officer 2013-12-17